Literature DB >> 18409009

The M235T polymorphism of the AGT gene modifies the risk of coronary artery disease associated with the presence of hypercholesterolemia.

Pawel Niemiec1, Iwona Zak, Krystian Wita.   

Abstract

OBJECTIVE: Atherosclerosis is an inflammatory disease resulting from interactions between various genetic and non-genetic factors. Angiotensinogen gene (AGT) belongs to polymorphic candidate genes. Recent evidence show that many traditional risk factors of coronary artery disease (CAD) influence synthesis of AGT. This report focuses on the interactions between M235T polymorphism of AGT gene and traditional risk factors of CAD.
MATERIAL AND METHODS: 255 subjects, including 158 patients with angiographically confirmed CAD and 97 blood donors without history of cardiovascular diseases were studied. M235T polymorphism of the AGT gene was genotyped using PCR-RFLP method. To determine the possible interactions of AGT genotypes and traditional risk factors of CAD the attributable proportion due to interaction (AP) and synergy models were used.
RESULTS: The frequency of 235T allele carriers was significantly higher in patients than in controls (77.8 vs. 62.9, OR = 2.20, 95% CI; 1.10-4.40, P = 0.026, in multivariate logistic regression model). We found the existence of interaction between the 235T allele carrier-state and hypercholesterolemia (total cholesterol > or = 5 mmol/l) increasing the risk of CAD (SI = 3.39, 95% CI; 1.33-8.66, AP = 0.65, 95% CI; 0.39-0.91). The 235T allele also interacted with elevated LDL cholesterol levels (> or = 3 mmol/l) (AP = 0.49, 95% CI; 0.20-0.96), but not with the hypertension, overweight/ obesity and cigarette smoking.
CONCLUSION: The 235T allele increases the risk of CAD associated with the presence of hypercholesterolemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18409009     DOI: 10.1007/s10654-008-9241-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  32 in total

1.  Structure and expression of the human angiotensinogen gene. Identification of a unique and highly active promoter.

Authors:  A Fukamizu; S Takahashi; M S Seo; M Tada; K Tanimoto; S Uehara; K Murakami
Journal:  J Biol Chem       Date:  1990-05-05       Impact factor: 5.157

2.  Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.

Authors:  Alan Daugherty; Debra L Rateri; Hong Lu; Tadashi Inagami; Lisa A Cassis
Journal:  Circulation       Date:  2004-12-13       Impact factor: 29.690

3.  Synergistic effect between apolipoprotein E and angiotensinogen gene polymorphisms in the risk for early myocardial infarction.

Authors:  A Batalla; R Alvarez; J R Reguero; S Hevia; G Iglesias-Cubero; V Alvarez; A Cortina; P González; M M Celada; A Medina; E Coto
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

4.  Contemporaneous carrier-state of two or three "proatherosclerotic" variants of APOE, ICAM1, PPARA and PAI-1 genes differentiate CAD patients from healthy individuals.

Authors:  Iwona Zak; Anna Balcerzyk; Beata Sarecka; Paweł Niemiec; Zbigniew Ciemniewski; Stanisław Dylag
Journal:  Clin Chim Acta       Date:  2005-07-25       Impact factor: 3.786

5.  Cross-talk between dyslipidemia and renin-angiotensin system and the role of LOX-1 and MAPK in atherogenesis studies with the combined use of rosuvastatin and candesartan.

Authors:  Jiawei Chen; Dayuan Li; Robert Schaefer; Jawahar L Mehta
Journal:  Atherosclerosis       Date:  2005-07-06       Impact factor: 5.162

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

7.  Upregulation of vascular angiotensin II receptor gene expression by low-density lipoprotein in vascular smooth muscle cells.

Authors:  G Nickenig; A Sachinidis; F Michaelsen; M Böhm; S Seewald; H Vetter
Journal:  Circulation       Date:  1997-01-21       Impact factor: 29.690

8.  Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.

Authors:  F Massiéra; M Bloch-Faure; D Ceiler; K Murakami; A Fukamizu; J M Gasc; A Quignard-Boulange; R Negrel; G Ailhaud; J Seydoux; P Meneton; M Teboul
Journal:  FASEB J       Date:  2001-10-15       Impact factor: 5.191

9.  Angiotensin II mediates LDL-induced superoxide generation in mesangial cells.

Authors:  So Yeon Park; Chi Young Song; Bong Cho Kim; Hye Kyoung Hong; Hyun Soon Lee
Journal:  Am J Physiol Renal Physiol       Date:  2003-07-01

10.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts).

Authors:  Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood
Journal:  Atherosclerosis       Date:  2004-04       Impact factor: 5.162

View more
  6 in total

Review 1.  The renin angiotensin aldosterone system and insulin resistance in humans.

Authors:  Patricia C Underwood; Gail K Adler
Journal:  Curr Hypertens Rep       Date:  2013-02       Impact factor: 5.369

Review 2.  Early influences on cardiovascular and renal development.

Authors:  J J Miranda Geelhoed; Vincent W V Jaddoe
Journal:  Eur J Epidemiol       Date:  2010-09-25       Impact factor: 8.082

3.  The Generation R Study: design and cohort update 2010.

Authors:  Vincent W V Jaddoe; Cock M van Duijn; Albert J van der Heijden; Johan P Mackenbach; Henriëtte A Moll; Eric A P Steegers; Henning Tiemeier; Andre G Uitterlinden; Frank C Verhulst; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2010-10-22       Impact factor: 8.082

4.  An Angiotensinogen Gene Polymorphism (rs5050) Is Associated with the Risk of Coronary Artery Aneurysm in Southern Chinese Children with Kawasaki Disease.

Authors:  Yunfeng Liu; Lanyan Fu; Lei Pi; Di Che; Yufen Xu; Hao Zheng; Haifeng Long; Lanlan Zeng; Ping Huang; Li Zhang; Tao Yu; Xiaoqiong Gu
Journal:  Dis Markers       Date:  2019-01-03       Impact factor: 3.434

5.  Recent trends in cardiovascular epidemiology.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2009       Impact factor: 8.082

6.  RAS gene polymorphisms, classical risk factors and the advent of coronary artery disease in the Portuguese population.

Authors:  Ana I Freitas; Isabel Mendonça; Maria Brión; Miguel M Sequeira; Roberto P Reis; Angel Carracedo; António Brehm
Journal:  BMC Cardiovasc Disord       Date:  2008-07-17       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.